From the Literature

Published: Feb 2015

Bouet PE, Ruiz V, Legendre G, Gillard P, Descamps P, Sentilhes L

High-dose tranexamic acid for treating postpartum haemorrhage after vaginal delivery.
Br J Anaesth 2015;114:339-341.

#

NATA REVIEW:
This report describes 60 women given high-dose tranexamic acid (4 g) if they sustained >800 mL...
REVIEW by:
B. J. Hunt

Published: Jan 2015

Godier A, Taylor G, Gaussem P

Inefficacy of platelet transfusion to reverse ticagrelor.
N Engl J Med 2015;372:196-197.

#

NATA REVIEW:
Godier and colleagues describe a patient on dual antiplatelet therapy with ticagrelor and aspirin due to two...
REVIEW by:
P. Johansson

Published: Jan 2015

Clifford L, Jia Q, Yadav H, et al.

Characterizing the epidemiology of perioperative transfusion-associated circulatory overload.
Anesthesiology 2015;122:21-28.

#

NATA REVIEW:
The paper by Clifford et al. reports on the results of a very interesting retrospective study evaluating...
REVIEW by:
G. Inghilleri

Published: Nov 2014

Leal-Noval SR, Casado M, Arellano-Orden V, et al.

Administration of fibrinogen concentrate for refractory bleeding in massively transfused, non-trauma patients with coagulopathy: a retrospective study with comparator group.
BMC Anesthesiol 2014;14:109.

#

NATA REVIEW:
Compensation of blood losses with infusion of crystalloidal and/or colloidal infusion solutions results in dilution...
REVIEW by:
O. Habler

Published: Oct 2014

Welsh KJ, Padilla A, Dasgupta A, Nguyen AN, Wahed A

Thromboelastography is a suboptimal test for determination of the underlying cause of bleeding associated with cardiopulmonary bypass and may not predict a hypercoagulable state.
Am J Clin Pathol 2014;142:492-497.

#

NATA REVIEW:
Welsh and colleagues investigated thrombelastography (TEG) and conventional coagulation tests (CCT) in 67 retrospectively...
REVIEW by:
J. Stensballe

Published: Oct 2014

Kasivisvanathan R, Abbassi-Ghadi N, Kumar S, et al.

Risk of bleeding and adverse outcomes predicted by thromboelastography platelet mapping in patients taking clopidogrel within 7 days of non-cardiac surgery.
Br J Surg 2014;101:1383-1390.

#

NATA REVIEW:
Kasivisvanathan and colleagues open the door a little further to tailored antiplatelet therapy, showing good...
REVIEW by:
J. Stensballe

Published: Oct 2014

Adelmann D, Wiegele M, Wohlgemuth RK, et al.

Measuring the activity of apixaban and rivaroxaban with rotational thrombelastometry.
Thromb Res 2014;134:918-923.

#

NATA REVIEW:
Although no routine coagulation monitoring is recommended during treatment with direct factor Xa inhibitors,...
REVIEW by:
D. Faraoni

Published: Oct 2014

Sullivan IJ, Faulds JN

Assessment of intra-operative cell salvage haemolysis in the obstetric and orthopaedic clinical setting, in comparison with allogeneic blood.
Transfus Med 2014;24:280-285.

#

NATA REVIEW:
This is an interesting report from an active group who have published widely on the topic of cell salvaged blood...
REVIEW by:
D. Thomas

Published: Aug 2014

Miceli A, Romeo F, Glauber M, de Siena PM, Caputo M, Angelini GD

Preoperative anemia increases mortality and postoperative morbidity after cardiac surgery.
J Cardiothorac Surg 2014;9:137.

#

NATA REVIEW:
The authors assessed the impact of preoperative anaemia (according to the WHO definition) on patient outcome...
REVIEW by:
S. Kozek-Langenecker

Published: Jul 2014

Smith GA, Fisher SA, Doree C, Di Angelantonio E, Roberts DJ

Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors.
Cochrane Database Syst Rev 2014;7:CD009532.

#

NATA REVIEW:
Iron supplementation in healthy blood donors to reduce donor deferral, iron deficiency and/or anaemia is a matter...
REVIEW by:
R. Moog

Pages